Zhengye Biotechnology Holding Limited (ZYBT) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Zhengye Biotechnology Holding Limited (ZYBT) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $35.5M, listed on NASDAQ, employing roughly 269 people, carrying a beta of -2.17 to the broader market. Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. Led by Songlin Song, public since 2025-01-07.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for ZYBT as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →